shatter

Colorado: Marijuana Trends Analysis Includes Comparisons With Washington State

ColoradoTotalCannabisSales3.8XGreaterThanWA[BDSAnalytics].jpg

Shatter is the most popular style of concentrate in Colorado, candy is the first edible choice for most cannabis consumers in the state, and sativa is more popular in Colorado than in Washington state.

This represents a small look at the sweeping range of insights released on Thursday through BDS Analytics’ GreenEdge™ database, which the company says is "the cannabis industry’s most reliable source of data analytics."

Among other things, the in-depth analysis of the Colorado cannabis market, with comparisons to trends in Washington state, finds:

• The top 10 flower strains in Colorado account for roughly 20 percent of total flower sales
• Durban Poison, a pure sativa, was the No. 1 strain in Colorado in Q4 2015
• Colorado’s leading edibles brands include Wana, Cheeba Chews, Incredibles and Dixie Elixirs
• Colorado’s total cannabis sales for 12-month period through Sept. 2015 were 3.8 times larger than Washington’s
• Data analysis reveals zero correlation between top strains in Washington and Colorado, other than popularity of Blue Dream, a sativa-dominant hybrid.

“We have now normalized and categorized millions of transactions in Colorado and Washington State in our GreenEdge™ database, which is the backbone of this detailed report,” said Roy Bingham, BDS Analytics founder and CEO. “Sales growth in both states remains impressive — compared to growth in other industries, it is jaw-dropping.

Colorado: Marijuana Often Laced With Pesticides, Heavy Metals and Fungus

AndyLaFrate

By Steve Elliott
Hemp News

Lab tests from Colorado indicate that while the legal cannabis on store shelves is more potent than the marijuana of 30 years ago, it is often contaminated with fungi, pesticides and heavy metals.

"There's a stereotype, a hippy kind of mentality, that leads people to assume that growers are using natural cultivation methods and growing organically," said Andy LaFrate, founder of Charas Scientific, one of eight labs in Colorado certified to test marijuana. "That's not necessarily the case at all."

LaFrate presented his findings this week at a meeting of the American Chemical Society (ACS) in Denver.

LaFrate said his group has tested more than 600 strains of marijuana from dozens of producers. Potency tests looked at tetrahydrocannabinol (THC), the principal psychoactive component responsible for the high. They found that modern cannabis contains THC levels of 18 to 30 percent, double to triple averages from the 1980s.

Breeding for more THC has led to less cannabidiol (CBD), a compound which is also medically beneficial in treating anxiety, depression, schizophrenia, Huntington's, Alzheimer's, epilepsy, seizures and other conditions. Much of the commercial marijuana tested had very little CBD.

"A lot of the time it's below the detection level of our equipment, or it's there at a very low concentration that we just categorize as a trace amount," LaFrate said.
"I've heard a lot of complains from medical patients because somebody claims that a product has a high level of CBD, and it turns out that it actually doesn't."

Syndicate content